Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

31.6%

6 terminated/withdrawn out of 19 trials

Success Rate

64.7%

-21.8% vs industry average

Late-Stage Pipeline

37%

7 trials in Phase 3/4

Results Transparency

64%

7 of 11 completed trials have results

Key Signals

2 recruiting7 with results

Enrollment Performance

Analytics

Phase 3
7(38.9%)
Phase 1
7(38.9%)
Phase 2
3(16.7%)
Early Phase 1
1(5.6%)
18Total
Phase 3(7)
Phase 1(7)
Phase 2(3)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials
NCT04053387Phase 3Completed

Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)

Role: collaborator

NCT03666780Completed

Lifetech LAmbre™ Left Atrial Appendage (LAA) Closure System Post-Market Clinical Follow-up Study

Role: collaborator

NCT03956355Phase 3Completed

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)

Role: collaborator

NCT03983980Phase 3Completed

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)

Role: collaborator

NCT05908084Phase 3Recruiting

To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis

Role: collaborator

NCT05030831Phase 1Completed

Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ABCC6 Deficiency Causing PXE

Role: collaborator

NCT06549946Phase 1Recruiting

Ixovex-1 Single Agent and Combination Therapy

Role: collaborator

NCT03464019Phase 3Terminated

Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT).

Role: collaborator

NCT05414422Phase 2Completed

A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD

Role: collaborator

NCT04072835Phase 3Completed

Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303

Role: collaborator

NCT04167137Phase 1Terminated

Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants

Role: collaborator

NCT04396340Phase 1Terminated

First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b

Role: collaborator

NCT02678572Phase 3Completed

Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma

Role: collaborator

NCT04907968Phase 1Terminated

Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer

Role: collaborator

NCT04188574Phase 2Completed

A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail

Role: collaborator

NCT05066698Phase 2Terminated

ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects

Role: collaborator

NCT04720378Phase 1Completed

Safety and Tolerability Study of IV ST266 in COVID-19 Subjects

Role: collaborator

NCT04123574Early Phase 1Withdrawn

A Pilot Study of BXCL701 in Patients With Pancreatic Cancer

Role: collaborator

NCT03466320Phase 1Completed

DEPLETHINK - LymphoDEPLEtion and THerapeutic Immunotherapy With NKR-2

Role: collaborator

All 19 trials loaded